A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers.

Marva SafaAudrey NatalizioChristopher K Hee

Published in: Clinical, cosmetic and investigational dermatology (2022)

VYC-12L produced changes in hydration, firmness, and ECM density and composition consistent with improved skin properties, demonstrating that VYC-12L can act as a substrate for tissue repair.

Keyphrases

open label
soft tissue
wound healing
clinical trial
randomized controlled trial
study protocol
phase ii
squamous cell carcinoma
ultrasound guided
quality improvement
phase iii
rectal cancer
double blind